The most important adverse events reported with erythropoietin administration are arterial hypertension, cerebral convulsion/hypertensive encephalopathy, thromboembolism, iron deficiency and influenza-like syndrome [30]. The gene discussed is EPO; the disease is Iron deficiency anemia.